- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04184739
Quality and Effectiveness of a Personalised App to Support Patients With Fixed Braces
Investigating the Quality and Effectiveness of a Personalised Mobile App Designed to Support Patients With Fixed (Train Track) Braces: A Randomised Controlled Trial (Student Study)
Mobile phones are potentially an invaluable tool in improving adherence, they are readily available and can utilised to deliver several approaches to improve adherence simultaneously. A personalised App to help support orthodontic patients ('My Braces') was therefore developed by the researchers. The App provides generic treatment information and also has a personalised element. The personalised element allows patients to input their own treatment information (including progress photographs), set goals, develop plans for achieving these and it provides the patient and clinicians with appropriate dashboards to monitor progress.
This research will be conducted at the Eastman Dental Hospital, UCLH Foundation Trust, London. The aim is to assess the effectiveness of the My Braces App, an App designed to support patients undergoing fixed orthodontic treatment.
Effectiveness of the My Braces App will be tested by way of a randomised controlled trial. Participants will be allocated to one of three groups:
Group A: Standard treatment information (verbal and written) and access to a basic version of the My Braces App with a toothbrushing timer. The timer is necessary as the health behaviour outcome is toothbrushing duration.
Group B: As for group A, however, additionally the My Braces App will provide generic treatment information (a combination of videos and text)
Group C: As for group B, however, the patients will have access to the full functionality of the My Braces App and the App will allow patients to input their own personalised treatment information (including progress photographs), set goals, develop plans for achieving these and provide the patient and clinicians with appropriate dashboards to monitor progress.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The National Child Dental Health Survey (England, Wales and Northern Ireland) indicated that 9% of 12 years olds are receiving orthodontic treatment (the use of braces to straighten teeth) and a further 37% have an unmet need. Treatment duration is lengthy (2-3 years on average) and adherence to treatment advice is essential for successful outcomes. It has been reported that up to 43% of patients fail to complete treatment and there are currently no useful predictors of non-completion. The NHS England annual spend on primary care orthodontics is in excess of £200 million, non-completion of treatment therefore represents a significant inefficient use of public resources.
Mobile phones are potentially an invaluable tool in improving adherence, they are readily available and can utilised to deliver several approaches to improve adherence simultaneously. A personalised App to help support orthodontic patients ('My Braces') was therefore developed by the researchers. The App provides generic treatment information and also has a personalised element. The personalised element allows patients to input their own treatment information (including progress photographs), set goals, develop plans for achieving these and it provides the patient and clinicians with appropriate dashboards to monitor progress.
This research will be conducted at the Eastman Dental Hospital, UCLH Foundation Trust, London. The aim is to assess the effectiveness of the My Braces App, an App designed to support patients undergoing fixed orthodontic treatment.
Effectiveness of the My Braces App will be tested by way of a randomised controlled trial. Participants will be allocated to one of three groups:
Group A: Standard treatment information (verbal and written) and access to a basic version of the My Braces App with a toothbrushing timer. The timer is necessary as the health behaviour outcome is toothbrushing duration.
Group B: As for group A, however, additionally the My Braces App will provide generic treatment information (a combination of videos and text)
Group C: As for group B, however, the patients will have access to the full functionality of the My Braces App and the App will allow patients to input their own personalised treatment information (including progress photographs), set goals, develop plans for achieving these and provide the patient and clinicians with appropriate dashboards to monitor progress.
It is important to include Group B as this will allow the team to ascertain whether it is the personalisation of the App content which infers any benefit over and above providing generic information via an App if a difference is found between Groups A and C.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Susan J Cunningham, PhD
- Phone Number: 02034561064
- Email: s.cunningham@ucl.ac.uk
Study Contact Backup
- Name: Mohammad O Sharif, MSc
- Email: mohammad.sharif.16@ucl.ac.uk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients accepted for orthodontic treatment utilising fixed orthodontic braces ('train track' braces) at the Eastman Dental Hospital, UCLH Foundation Trust (UCLH EDH)
- 10-18 years (inclusive) at the start of treatment
- Familiarity with, and daily access to, a smartphone/tablet • Ability to read and communicate in English
Exclusion Criteria:
- Craniofacial/Orthognathic patients or those with severe hypodontia (developmental absence of teeth); these patients require complex multi-disciplinary treatment. The information need for these patients is therefore different to routine orthodontic treatment
- Communication difficulties (for example, severe autism, learning difficulties)
- Patients who are aware that a family member/friend is enrolled in the study (including a preceding feasibility study, the pilot or RCT) - this is to avoid the patient potentially having access to parts of the App relating to groups other than that the patient is allocated to
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group A
Standard treatment information (verbal and written) and access to a basic version of the App with a toothbrushing timer.
The timer is necessary as the health behaviour outcome is toothbrushing duration.
|
An App designed to support patients undertaking orthodontic treatment.
|
Experimental: Group B
As for group A, however, additionally the App will provide generic treatment information (a combination of videos and text)
|
An App designed to support patients undertaking orthodontic treatment.
|
Experimental: Group C
As for group B, however, the patients will have access to the full functionality of the App and the App will allow patients to input their own personalised treatment information (including progress photographs), set goals, develop plans for achieving these and provide the patient and clinicians with appropriate dashboards to monitor progress.
|
An App designed to support patients undertaking orthodontic treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Toothbrushing duration
Time Frame: 3 months
|
Timed toothbrush use will be determined via the information stored on the App.
It is anticipated that participants will not remember to time each brushing episode, therefore, the duration and number of brushing sessions stored within the App will allow for the average brushing duration to be determined.
The unit of measurement will be seconds.
|
3 months
|
Toothbrushing duration
Time Frame: 12 months
|
Timed toothbrush use will be determined via the information stored on the App.
It is anticipated that participants will not remember to time each brushing episode, therefore, the duration and number of brushing sessions stored within the App will allow for the average brushing duration to be determined.
The unit of measurement will be seconds.
|
12 months
|
Toothbrushing duration
Time Frame: End of treatment (24-36 months on average)
|
Timed toothbrush use will be determined via the information stored on the App.
It is anticipated that participants will not remember to time each brushing episode, therefore, the duration and number of brushing sessions stored within the App will allow for the average brushing duration to be determined.
The unit of measurement will be seconds.
|
End of treatment (24-36 months on average)
|
Bleeding score
Time Frame: Base line (start of treatment)
|
A periodontal probe will be utilised, the presence of bleeding within 10 to 30 seconds of probing is indicative of inflammation of the gingivae.
Scores will be recorded for all teeth anterior to the molars (incisors, canines and premolars) and will be recorded as the percentage of the total number of tooth surfaces (6 aspects per tooth).
A binary score will be assigned to each surface (1 bleeding present, 0 no bleeding).
|
Base line (start of treatment)
|
Bleeding score
Time Frame: 3 months
|
A periodontal probe will be utilised, the presence of bleeding within 10 to 30 seconds of probing is indicative of inflammation of the gingivae.
Scores will be recorded for all teeth anterior to the molars (incisors, canines and premolars) and will be recorded as the percentage of the total number of tooth surfaces (6 aspects per tooth).
A binary score will be assigned to each surface (1 bleeding present, 0 no bleeding).
|
3 months
|
Bleeding score
Time Frame: 12 months
|
A periodontal probe will be utilised, the presence of bleeding within 10 to 30 seconds of probing is indicative of inflammation of the gingivae.
Scores will be recorded for all teeth anterior to the molars (incisors, canines and premolars) and will be recorded as the percentage of the total number of tooth surfaces (6 aspects per tooth).
A binary score will be assigned to each surface (1 bleeding present, 0 no bleeding).
|
12 months
|
Bleeding score
Time Frame: End of treatment (24-36 months on average)
|
A periodontal probe will be utilised, the presence of bleeding within 10 to 30 seconds of probing is indicative of inflammation of the gingivae.
Scores will be recorded for all teeth anterior to the molars (incisors, canines and premolars) and will be recorded as the percentage of the total number of tooth surfaces (6 aspects per tooth).
A binary score will be assigned to each surface (1 bleeding present, 0 no bleeding).
|
End of treatment (24-36 months on average)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plaque score
Time Frame: Base line (start of treatment), 3 months, 12 months, and at the end of treatment (24-36 months on average)
|
Plaque scores will be recorded for all teeth anterior to the molars (incisors, canines and premolars) as the percentage of total surfaces (6 aspects per tooth).
A plaque disclosing agent will be used for the plaque assessment.
A binary score will be assigned to each surface (1 plaque present, 0 no plaque present).
|
Base line (start of treatment), 3 months, 12 months, and at the end of treatment (24-36 months on average)
|
Number of breakages
Time Frame: 3 months, 12 months, and at the end of treatment (24-36 months on average)
|
Information relating to the number of breakages will be obtained from the patient's medical records.
|
3 months, 12 months, and at the end of treatment (24-36 months on average)
|
Number of missed appointments
Time Frame: 3 months, 12 months, and at the end of treatment (24-36 months on average)
|
Information relating to the number of missed appointments will be obtained from the patient's medical records.
|
3 months, 12 months, and at the end of treatment (24-36 months on average)
|
Total number of appointments
Time Frame: At the end of treatment (24-36 months on average)
|
Information relating to the number of missed or rescheduled appointments and emergency appointments will be obtained from the patient's medical records.
|
At the end of treatment (24-36 months on average)
|
Treatment duration
Time Frame: At the end of treatment (24-36 months on average)
|
Information relating to treatment duration will be obtained from the patient's medical records.
|
At the end of treatment (24-36 months on average)
|
Enamel demineralisation on the front 6 teeth using standardised photographs
Time Frame: Base line (start of treatment) and at the end of treatment (24-36 months on average)
|
For the evaluation of demineralisation, photographs will be assessed and the severity of enamel demineralization will be recorded. The labial surfaces of the upper incisors and canines will be scored as follows:
|
Base line (start of treatment) and at the end of treatment (24-36 months on average)
|
App subjective quality
Time Frame: 3 months and at the end of treatment (24-36 months on average)
|
Patients will be asked to complete sections E and F of the uMARS questionnaire to ascertain perceived App quality.
|
3 months and at the end of treatment (24-36 months on average)
|
App engagement (pages accessed and whether this changes with time)
Time Frame: 3 months, 12 months, and at the end of treatment (24-36 months on average)
|
Data relating to App usage will be obtained from the Google Firebase system.
|
3 months, 12 months, and at the end of treatment (24-36 months on average)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Susan J Cunningham, PhD, UCL Professor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 124581
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment Adherence and Compliance
-
Cerina TherapeuticsUniversity of Ulster; European CommissionRecruitingTreatment Adherence | Treatment Adherence and Compliance | Generalized AnxietyUnited Kingdom
-
Universidad de SantanderUnknownTreatment Adherence and ComplianceColombia
-
Cairo UniversityCompletedTreatment Adherence and ComplianceEgypt
-
Universiti Putra MalaysiaNot yet recruitingTreatment Adherence and CompliancePakistan
-
University of ValenciaEnrolling by invitation
-
Istituto Auxologico ItalianoIstituti Clinici Scientifici Maugeri SpA; Politecnico di MilanoNot yet recruitingHypertension | Treatment Adherence and Compliance | Digital Health
-
San Diego State UniversityNational Institute of Mental Health (NIMH); Hennepin Healthcare Research InstituteCompleted
-
Massachusetts General HospitalRecruitingBreast Cancer | Treatment Adherence | Survivorship | Treatment Refusal | Treatment ComplianceUnited States
-
University of ValenciaRecruiting
-
University Hospital, GenevaCompletedPsychiatric Disorder | Treatment Adherence and ComplianceSwitzerland
Clinical Trials on My Braces App
-
University of AlbertaAlberta Health services; Ontario Bioscience Innovation OrganizationCompleted
-
Cedars-Sinai Medical CenterUniversity of Michigan; NestléCompleted
-
Damascus UniversityCompletedCrowding, ToothSyrian Arab Republic
-
Fundación Universitaria CIEOUnknownMalocclusion, Angle Class I
-
Texas A&M UniversityCompletedMalocclusion, Angle Class IIUnited States
-
University Health Network, TorontoOntario Centres of ExcellenceCompleted
-
Cairo UniversityRecruitingMalocclusion | Crowding, Tooth | Long Face SyndromeEgypt
-
King's College LondonUnknown
-
The Royal Wolverhampton Hospitals NHS TrustCompletedDiabetes | Care DeliveryUnited Kingdom
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed